Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 22.87 CNY -1.12% Market Closed
Market Cap: 7B CNY
Section:
 

Relative Value

The Relative Value of one Sirio Pharma Co Ltd stock under the Base Case scenario is 36.27 CNY. Compared to the current market price of 22.87 CNY, Sirio Pharma Co Ltd is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
36.27 CNY
Undervaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.6
P/S
P/S
Price to Sales
1.6
vs History
76
vs Industry
32
Median 3Y
1.7
Median 5Y
1.8
Industry
1.1
Forward
1.5
More Details
20.4
P/E
P/E
Price to Earnings
20.4
vs History
74
vs Industry
29
Median 3Y
21
Median 5Y
24
Industry
18
Forward
19.9
More Details
10.1
P/OCF
P/OCF
Price to OCF
10.1
vs History
87
vs Industry
24
Median 3Y
13.2
Median 5Y
14.3
Industry
11.6
More Details
34.6
P/FCFE
P/FCFE
Price to FCFE
34.6
vs History
42
vs Industry
11
Median 3Y
38.1
Median 5Y
26.8
Industry
15.3
More Details
2.8
P/B
P/B
Price to Book Value
2.8
vs History
30
vs Industry
23
Median 3Y
2.4
Median 5Y
2.4
Industry
1.6
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
68
vs Industry
31
Median 3Y
1.9
Median 5Y
1.9
Industry
1.2
Forward
1.8
More Details
5.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.8
vs History
73
vs Industry
29
Median 3Y
6
Median 5Y
6.3
Industry
3.9
More Details
17.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.9
vs History
63
vs Industry
22
Median 3Y
18.4
Median 5Y
19.2
Industry
10.4
Forward
10.4
More Details
17.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
17.9
vs History
63
vs Industry
26
Median 3Y
18.4
Median 5Y
19.2
Industry
13.3
Forward
21.4
More Details
11.7
EV/OCF
EV/OCF
Enterprise Value to OCF
11.7
vs History
80
vs Industry
22
Median 3Y
13.9
Median 5Y
15.7
Industry
12.3
More Details
39.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
39.4
vs History
41
vs Industry
0
Median 3Y
40.3
Median 5Y
23.4
Industry
15.3
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
58
vs Industry
30
Median 3Y
1.7
Median 5Y
1.8
Industry
1.2
More Details

Multiples Across Competitors

Competitors Multiples
Sirio Pharma Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Sirio Pharma Co Ltd
SZSE:300791
7B CNY 1.6 20.4 17.9 17.9
FR
L'Oreal SA
PAR:OR
196.4B EUR 4.5 32.2 18.6 22.7
UK
Unilever PLC
LSE:ULVR
118.1B GBP 2.3 24.3 164.7 192
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.4T INR 8.4 49.7 36 39.9
UK
HALEON PLC
LSE:HLN
31.7B GBP 2.8 22 13.4 15.2
US
Estee Lauder Companies Inc
NYSE:EL
37B USD 2.6 -39.8 20.2 33.4
DE
Beiersdorf AG
XETRA:BEI
20.3B EUR 2.1 22.9 11.3 14.5
JP
Kao Corp
TSE:4452
2.9T JPY 1.7 23.9 11.4 17.5
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR 7.8 63.6 39.5 43.3
MY
Bioalpha Holdings Bhd
KLSE:BIOHLDG
43.5B MYR 1 691.5 -1 010 -1 816.5 -1 377
IN
Dabur India Ltd
NSE:DABUR
890.4B INR 7 49.2 36.9 45.7
P/E Multiple
Earnings Growth PEG
CN
Sirio Pharma Co Ltd
SZSE:300791
Average P/E: 34.2
20.4
19%
1.1
FR
L'Oreal SA
PAR:OR
32.2
8%
4
UK
Unilever PLC
LSE:ULVR
24.3
13%
1.9
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
49.7
8%
6.2
UK
HALEON PLC
LSE:HLN
22
12%
1.8
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -39.8 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
22.9
8%
2.9
JP
Kao Corp
TSE:4452
23.9
12%
2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
63.6
19%
3.3
MY
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Negative Multiple: -1 010 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
49.2
12%
4.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Sirio Pharma Co Ltd
SZSE:300791
Average EV/EBITDA: 37
17.9
28%
0.6
FR
L'Oreal SA
PAR:OR
18.6
5%
3.7
UK
Unilever PLC
LSE:ULVR
164.7
2%
82.3
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36
8%
4.5
UK
HALEON PLC
LSE:HLN
13.4
4%
3.3
US
Estee Lauder Companies Inc
NYSE:EL
20.2
15%
1.3
DE
Beiersdorf AG
XETRA:BEI
11.3
-1%
N/A
JP
Kao Corp
TSE:4452
11.4
8%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
39.5
13%
3
MY
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Negative Multiple: -1 816.5 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
36.9
11%
3.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Sirio Pharma Co Ltd
SZSE:300791
Average EV/EBIT: 44.2
17.9
9%
2
FR
L'Oreal SA
PAR:OR
22.7
6%
3.8
UK
Unilever PLC
LSE:ULVR
192
2%
96
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
39.9
9%
4.4
UK
HALEON PLC
LSE:HLN
15.2
4%
3.8
US
Estee Lauder Companies Inc
NYSE:EL
33.4
25%
1.3
DE
Beiersdorf AG
XETRA:BEI
14.5
-1%
N/A
JP
Kao Corp
TSE:4452
17.5
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
43.3
13%
3.3
MY
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Negative Multiple: -1 377 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
45.7
11%
4.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 302,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.